← Back to patent-cliff list
Miltefosine
Tier C — Watch / tradeMiltefosine
-
Originator
2002
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：Not applicable
Brand：Miltex, Impavido, Miltefosin
Indications (approved)：利什曼原虫感染
Regional status
US
Approved
2014-03-19
EU
Discontinued
2008-09-01
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Miltefosine?
Approved indications include: 利什曼原虫感染.
When does the Miltefosine patent expire?
No public expiry year is available for Miltefosine yet; this page updates once verified.
How do I get a quote for Miltefosine intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-27